Press Release: EP Interest Group on Allergy and Asthma
Launch of new European Parliament Interest Group on Allergy and Asthma
Brussels, 25 March, 2015 – Members of the European Parliament (MEPs), patients,...
COPD explained
Hello,
If you are reading this article because you or someone close to you live with COPD, do not worry, you are not alone. Approximately 5-10% of all...
Allergy explained
Hello,
If you are reading this article because you or someone close to you live with allergies, do not worry, you are not alone. At EFA, we represent...
Asthma explained
Hello,
If you are reading this article because you or someone close to you live with asthma, do not worry, you are not alone.
In Europe, 30 million of...
EFA Board
EFA President - Mikaela Odemyr
Since 2010 I am a Board Member of the Swedish Asthma and Allergy Foundation and since 2013 I am 2nd Vice-President....
EFA Board (2)
EFA President - Mikaela Odemyr
Since 2010 I am a Board Member of the Swedish Asthma and Allergy Foundation and since 2013 I am 2nd Vice-President....
EFA Board (3)
EFA President - Mikaela Odemyr
Since 2010 I am a Board Member of the Swedish Asthma and Allergy Foundation and since 2013 I am 2nd Vice-President....
Boosting Health Literacy for Adolescents with Asthma - EFA project
Asthma is the most common chronic disease in childhood although symptoms and disease can cease before adulthood with adequate treatment. Today, 30 million...
Relieve the burden of allergies - EFA project
Allergology is not recognised as a medical specialisation in most European countries and respiratory allergies are often treated at primary care services....
EARIP - EU funded project
Europe is one of the most affected regions by asthma prevalence in adults. The European Asthma Research and Innovation Partnership (EARIP) aims to reduce...
AirPROM - EU funded project
Our lungs may look similar, but they are not exactly the same. They differ on shape, capacity and properties just like our eyes do not have the same colour....
EFA Capacity Building Project (ongoing)
EFA consists of 38 national patient associations from across Europe, each organistaion varies in their disease focus, capacity and resources. Through capacity...
Clinical trials for asthma, allergy and COPD
Clinical trials are research conducted in humans to prove the effects of one or more investigational medicinal products. All investigational medicinal...
Medical devices for allergy and respiratory diseases
Medical devices can increase life expectancy and quality of life. They are also fundamental for chronic disease patients as they help them manage their...
Press Release: Beware of Allergy campaign
FOOD ALLERGY: a burden carried by more than 17 million of Europeans
In Europe, 1 out of every 20 children has one or more food allergies
In the...
Press Release: International Women's Day
Take action to decrease the burden of asthma in women
Brussels, 8 March 2015, INTERNATIONAL WOMEN’S DAY – In the European Union women live on average...
Chronic diseases in Europe (February 2015)
February has been an enriching month in the fight against chronic diseases prevalence and burden in Europe: two main events have been organised in The...
EFA Members News (February 2015)
Patient-led initiatives not only bring meaningful results for patients, but also broader support. In February, EFA Dutch Member Longfonds was awarded with...
EU Projects update (February 2015)
EFA’s role in EU funded research projects is to provide the patients persepective to the research process and to ensure that patietns are updated on...
New air quality guidelines (February 2015)
Air quality is an increasingly worrying topic both at EU and global level. The World Health Organisation prepares a resolution that takes stock of air...